Invensys presents approach for measuring economic benefit of process analytical technologies (PAT)


FOXBORO, MASS. - November 2, 2005 - Invensys' Dr. Peter G. Martin, author and noted authority on real-time performance management, will present a seminar that will help pharmaceutical and biopharmaceutical scientists and manufacturers apply process analytical technologies (PAT) more strategically. Dr. Martin's seminar, entitled "Optimizing PAT with Metrics that Matter," will be presented on November 9, 2005 to members of the International Society for Pharmaceutical Engineers (ISPE) at their 2005 annual meeting in Scottsdale, Arizona.

"With PAT, the FDA has opened the door for pharmaceutical manufacturers to achieve the performance optimization benefits that are already being realized in many other industries," said Janice Abel, director of pharmaceutical and biopharmaceutical marketing for Invensys and past president of the ISPE Boston chapter. "Dr. Martin's seminar will help pharmaceutical and biopharmaceutical manufacturers to measure economic performance in real time and thus be able to quantify and justify the benefits of implementing PAT in their plants."

The seminar will guide the pharmaceutical and biopharmaceutical industries in implementing programs to realize measurable benefits from PAT-related process optimization. Martin will demonstrate ways of developing measures that correlate with meaningful business metrics to help life science developers and manufacturers cut costs, improve product quality, or speed to market, depending on their business strategy.

Dr. Martin, vice president of performance management at Invensys Process Systems in Foxboro, Massachusetts, is author of Bottom Line Automation and Dynamic Performance Management: The Pathway to World Class Manufacturing (both by ISA Press) as well as numerous articles and technical papers. The Instrumentation, Systems, and Automation (ISA) Society's InTech magazine has named him one of the 50 most influential people in the control industry and Fortune magazine named him a "Hero of US Manufacturing."

More than 50 companies throughout the world are now implementing one or more programs based on Dr. Martin's patented "dynamic performance measures" method of providing instant, high-resolution economic feedback of how plant activities are impacting profitability. Dr. Martin has held positions in engineering, product planning, marketing and strategic planning at The Foxboro Company and Invensys Process Systems, and was also vice president at Automation Research Corporation (ARC). He holds B.A. and M.S. degrees in Mathematics, an M.A. degree in Administration and Management, and a Ph.D. in Industrial Engineering.

About Invensys Process Systems

Invensys Process Systems, a business unit of Invensys plc, provides products, services and solutions that enable today's industrial process plants to monitor, manage, and improve the performance of their manufacturing assets while complying with global regulatory requirements. In addition to its rapidly expanding Global Solutions group, Invensys Process Systems includes industry-leading brands such as Foxboro, SimSci-Esscor, Validation Technologies, Wonderware, and Avantis, whose products and services are installed in more than 100,000 plants across the world. These range from small hybrid and batch plants to the world's largest upstream projects, refineries, gas plants, petrochemicals plants, power plants, and pulp and paper mills.

The Invensys Group (www.invensys.com) is made up of five businesses: Process Systems, APV, Eurotherm, Rail Systems and Controls. The Group is headquartered in London and is listed on the London Stock Exchange, with over 30,000 employees working in 60 countries.

All Topics